US private equity firm MSMB Capital Management on Wednesday said it had offered to buy the shares of biopharmaceutical firm Amag
) not already owned by it at USD18.
Salient Systems and AMAG
can now offer an 'integrated security solution' combining their access control and management platform with our powerful video surveillance management system in a single flexible and easy to use interface.
10 October 2011 - US biopharmaceutical company Allos Therapeutics Inc (NASDAQ:ALTH) said today that it continues to work with local peer AMAG
Pharmaceuticals Inc (NASDAQ:AMAG
) towards the completion of their merger, subject to stockholder approval and satisfaction of other closing conditions.
Under the terms of the definitive agreement, Amag
will exchange 0.
The therapy was launched commercially in the US by AMAG
in July 2009.
Thomas, who has served as interim CEO of the company since November 2011, will return to his role of executive vice president and chief operating officer of AMAG
Concurrently, the company has permitted its largest shareholder, Adage Capital, to increase its equity ownership in AMAG
up to 25%, subject to certain conditions.
Brian Pereira, president and chief executive officer of AMAG
Pharmaceuticals, said that the company is pleased to have Lesley join AMAG
and is thankful to Mark for his years of service to AMAG
In conjunction with the trial, AMAG
intends to submit a sNDA for the broader US label for Feraheme to the US Food and Drug Administration in the second half of 2012.
MSMB Capital Management today announced that it has made a proposal to the board of directors of Amag
Pharmaceuticals Inc (Nasdaq:AMAG
) to acquire all of the outstanding shares of common stock of Amag
for USD18 per share in cash or an aggregate of USD378m.
implemented a restructuring plan on November 4, 2011 to align its operating expenses with projected Feraheme revenues.
announced the successful regulatory outcome of the Makena subcutaneous auto injector collaboration with AMAG